NRG Oncology
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2014-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.nrgoncology.org
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
- Conditions
- Interventions
- First Posted Date
- 2017-12-11
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 698
- Registration Number
- NCT03367702
- Locations
- 🇺🇸
Kaiser Permanente-Rancho Cordova Cancer Center, Rancho Cordova, California, United States
🇺🇸Mercy Cancer Center - Rocklin, Rocklin, California, United States
🇺🇸Rohnert Park Cancer Center, Rohnert Park, California, United States
Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer
- Conditions
- Interventions
- First Posted Date
- 2017-09-07
- Last Posted Date
- 2024-11-28
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 296
- Registration Number
- NCT03274687
- Locations
- 🇺🇸
Los Angeles General Medical Center, Los Angeles, California, United States
🇺🇸UCHealth University of Colorado Hospital, Aurora, Colorado, United States
🇺🇸UW Health Carbone Cancer Center Rockford, Rockford, Illinois, United States
Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery
- Conditions
- Interventions
- First Posted Date
- 2017-06-15
- Last Posted Date
- 2024-05-30
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 175
- Registration Number
- NCT03188393
- Locations
- 🇺🇸
Anne Arundel Medical Center, Annapolis, Maryland, United States
🇺🇸Emory Saint Joseph's Hospital, Atlanta, Georgia, United States
🇺🇸Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States
Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer
- Conditions
- Interventions
- First Posted Date
- 2017-06-14
- Last Posted Date
- 2024-11-28
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 186
- Registration Number
- NCT03186898
- Locations
- 🇺🇸
Corewell Health Dearborn Hospital, Dearborn, Michigan, United States
🇺🇸Corewell Health William Beaumont University Hospital, Royal Oak, Michigan, United States
🇺🇸Corewell Health Beaumont Troy Hospital, Troy, Michigan, United States
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
- Conditions
- Interventions
- First Posted Date
- 2017-06-08
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 148
- Registration Number
- NCT03180268
- Locations
- 🇺🇸
Kaiser Permanente-Bellflower, Bellflower, California, United States
🇺🇸California Pacific Medical Center-Pacific Campus, San Francisco, California, United States
🇺🇸The James Graham Brown Cancer Center at University of Louisville, Louisville, Kentucky, United States
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
- First Posted Date
- 2017-06-08
- Last Posted Date
- 2022-03-08
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 230
- Registration Number
- NCT03180294
- Locations
- 🇺🇸
Trinity Regional Medical Center, Fort Dodge, Iowa, United States
🇺🇸Southeastern Medical Oncology Center-Jacksonville, Jacksonville, North Carolina, United States
🇺🇸Saint Vincent Hospital Cancer Center at Oconto Falls, Oconto Falls, Wisconsin, United States
Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma
- Conditions
- Interventions
- First Posted Date
- 2017-06-08
- Last Posted Date
- 2024-03-21
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 148
- Registration Number
- NCT03180502
- Locations
- 🇺🇸
University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, United States
🇺🇸Central Maryland Radiation Oncology in Howard County, Columbia, Maryland, United States
🇺🇸Maryland Proton Treatment Center, Baltimore, Maryland, United States
Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2017-05-03
- Last Posted Date
- 2024-04-05
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 218
- Registration Number
- NCT03137771
- Locations
- 🇺🇸
Emory Saint Joseph's Hospital, Atlanta, Georgia, United States
🇺🇸USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery
- Conditions
- Interventions
- First Posted Date
- 2017-03-06
- Last Posted Date
- 2024-11-29
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 612
- Registration Number
- NCT03070886
- Locations
- 🇺🇸
Kaiser Permanente Sacramento Medical Center, Sacramento, California, United States
🇺🇸Henry Ford Health Saint John Hospital, Detroit, Michigan, United States
🇺🇸MyMichigan Medical Center Saginaw, Saginaw, Michigan, United States
Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer
- Conditions
- Interventions
- First Posted Date
- 2016-04-05
- Last Posted Date
- 2022-02-15
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 11
- Registration Number
- NCT02728258
- Locations
- 🇺🇸
The Mark H Zangmeister Center, Columbus, Ohio, United States
🇺🇸University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States
🇺🇸Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States